BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3588404)

  • 1. Flow cytometric analysis of the DNA profile of renal cell carcinoma.
    Ekfors TO; Lipasti J; Nurmi MJ; Eerola E
    Pathol Res Pract; 1987 Feb; 182(1):58-62. PubMed ID: 3588404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of flow cytometry in the prognosis of tumors of the kidney in adults].
    Sibert L; Laquerrière A; Czernichow P; Dadoun D; Hemet J; Grise P
    Ann Urol (Paris); 1989; 23(6):476-81. PubMed ID: 2694924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
    Ljungberg B; Mehle C; Stenling R; Roos G
    Br J Cancer; 1996 Jul; 74(1):123-7. PubMed ID: 8679445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA content in renal cell carcinoma. A comparison between flow and static cytometric methods.
    Roos G; Stenling R; Ljungberg B
    Scand J Urol Nephrol; 1986; 20(4):295-300. PubMed ID: 3810059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-cytometric DNA analysis of paraffin-embedded renal cell carcinoma tissue from patients treated by parenchymal-sparing surgery.
    Ciancio G; Ferrell S; Block NL
    Br J Urol; 1995 Nov; 76(5):570-4. PubMed ID: 8535674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma.
    Grignon DJ; el-Naggar A; Green LK; Ayala AG; Ro JY; Swanson DA; Troncoso P; McLemore D; Giacco GG; Guinee VF
    Cancer; 1989 Mar; 63(6):1161-5. PubMed ID: 2917319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
    Ljungberg B; Larsson P; Stenling R; Roos G
    J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
    al-Abadi H; Nagel R
    J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
    Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
    Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the anal canal and flow cytometric DNA analysis.
    Scott NA; Beart RW; Weiland LH; Cha SS; Lieber MM
    Br J Cancer; 1989 Jul; 60(1):56-8. PubMed ID: 2803916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
    Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver.
    Balsells J; Caragol I; Allende E; Diaz I; Charco R; Lazaro JL; Murio E; Margarit C
    J Hepatol; 1996 Dec; 25(6):854-8. PubMed ID: 9007713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study.
    Baretton G; Carstensen O; Schardey M; Löhrs U
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):301-9. PubMed ID: 2024451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.